over the counter glp 1 alternative OTC GLP-1 Alternatives vs. Prescription: Biomarker Insights GLP-1 Medications for Weight Loss

Errafii et al

Influence of glucagon-like peptide-1 receptor agonists on renal parameters: A meta-analysis of randomized controlled trials

Inflammation and endotyping in chronic Rhinosinusitis-A paradigm Shift

Conflict of interest statement Within the last 36 months, FK has served on scientific advisory panels and/or been part of speaker's bureaus for, served as a consultant to and/or received research support from Amgen, AstraZeneca, Boehringer Ingelheim, Eli Lilly, Gubra, MedImmune, MSD/Merck, Mundipharma, Norgine, Novo Nordisk, Sanofi and Zealand Pharma

Newer drugs like Mounjaro (Tirzepatide) combine GLP-1 and GIP (Glucose-Dependent Insulinotropic Peptide) effects